Tanemura, A., Terando, A. M., Sim, M., van Hoesel, A. Q., de Maat, M. F., Morton, D. L., & Hoon, D. S. (2009). CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma. Clinical cancer research, 15(5), 1801-1807. https://doi.org/10.1158/1078-0432.CCR-08-1361
Chicago Style (17th ed.) CitationTanemura, Atsushi, Alicia M. Terando, Myung-Shin Sim, Anneke Q. van Hoesel, Michiel F.G de Maat, Donald L. Morton, and Dave S.B Hoon. "CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma." Clinical Cancer Research 15, no. 5 (2009): 1801-1807. https://doi.org/10.1158/1078-0432.CCR-08-1361.
MLA (9th ed.) CitationTanemura, Atsushi, et al. "CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma." Clinical Cancer Research, vol. 15, no. 5, 2009, pp. 1801-1807, https://doi.org/10.1158/1078-0432.CCR-08-1361.